In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Manufacturing Operations, heads of regulatory affairs, and commercial directors from monoethanolamine producers, petrochemical firms, and chemical distributors were examples of supply-side sources. Procurement heads from agrochemical companies, R&D directors from personal care and cosmetics formulators, technical directors from textile processing companies, supply chain managers from pharmaceutical manufacturers, and category managers from manufacturers of industrial cleaning products were examples of demand-side sources. In addition to gathering information on feedstock pricing dynamics, formulation adoption patterns, and regional supply-demand imbalances, primary research verified market segmentation and capacity growth timetables.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (32%), Europe (29%), Asia-Pacific (34%), Rest of World (5%)
Global market valuation was derived through production capacity analysis and application segment revenue mapping. The methodology included:
Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Middle East & Africa
Product mapping across surfactants, agriculture, personal care, pharmaceuticals, and fiber treatment applications
Analysis of reported and modeled annual revenues specific to monoethanolamine and ethanolamine product portfolios
Coverage of manufacturers representing 75-80% of global production capacity in 2024
Extrapolation using bottom-up (production volume × ASP by region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations and concentration-grade pricing differentials